09.30.25 -- RWD Helps Abbvie Bridge Oncology Trial Data Gaps

Edward Bartels, an expert in eCOA solutions, provides an in-depth overview of the market trends, emerging technologies, and how IQVIA eCOA is pioneering advancements in this space.

Real-world data (RWD) is increasingly vital for advancing breast cancer research, and leveraging TA datasets allows researchers and clinicians to address pressing challenges.

Whether you’re heading toward clinical trials or on the path to commercialization, implement technology infrastructure that keeps pace.

Collecting quality data on patient outcomes is often one of the most important parts of a clinical trial. It is also challenging, and many eCOA solutions make it feel even more difficult.